Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver
- PMID: 19056767
- DOI: 10.1152/ajpgi.00462.2007
Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver
Abstract
Statins exert beneficial effects in chronically damaged tissues. Angiotensin II (ANG II) participates in liver fibrogenesis by inducing oxidative stress, inflammation, and transforming growth factor-beta1 (TGF-beta1) expression. We investigate whether atorvastatin modulates ANG II-induced pathogenic effects in the liver. Male Wistar rats were infused with saline or ANG II (100 ng kg(-1) min(-1)) for 4 wk through a subcutaneous osmotic pump. Rats received either vehicle or atorvastatin (5 mg kg(-1) day(-1)) by gavage. ANG II infusion resulted in infiltration of inflammatory cells (CD43 immunostaining), oxidative stress (4-hydroxynonenal), hepatic stellate cells (HSC) activation (smooth muscle alpha-actin), increased intercellular adhesion molecule (ICAM-1), and interleukin-6 hepatic gene expression (quantitative PCR). These effects were markedly blunted in rats receiving atorvastatin. The beneficial effects of atorvastatin were confirmed in an additional model of acute liver injury (carbon tetrachloride administration). We next explored whether the beneficial effects of atorvastatin on ANG II-induced actions are also reproduced at the cellular level. We studied HSC, a cell type with inflammatory and fibrogenic properties. ANG II (10(-8)M) stimulated cell proliferation, proinflammatory actions (NF-kappaB activation, ICAM-1 expression, interleukin-8 secretion) as well as expression of procollagen-alpha(1(I)) and TGF-beta1. All of these effects were reduced in the presence of atorvastatin (10(-7)M). These results indicate that atorvastatin attenuates the pathogenic events induced by ANG II in the liver both in vivo and in vitro. Therefore, statins could have beneficial effects in conditions characterized by hepatic inflammation.
Similar articles
-
Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress.Hypertension. 2009 Jul;54(1):142-9. doi: 10.1161/HYPERTENSIONAHA.109.133710. Epub 2009 May 18. Hypertension. 2009. PMID: 19451411
-
Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.BMC Gastroenterol. 2015 Feb 15;15:22. doi: 10.1186/s12876-015-0248-8. BMC Gastroenterol. 2015. PMID: 25886887 Free PMC article.
-
Atorvastatin inhibits proliferation and apoptosis, but induces senescence in hepatic myofibroblasts and thereby attenuates hepatic fibrosis in rats.Lab Invest. 2012 Oct;92(10):1440-50. doi: 10.1038/labinvest.2012.106. Epub 2012 Aug 13. Lab Invest. 2012. PMID: 22890553
-
Beneficial effects of naringenin in liver diseases: Molecular mechanisms.World J Gastroenterol. 2018 Apr 28;24(16):1679-1707. doi: 10.3748/wjg.v24.i16.1679. World J Gastroenterol. 2018. PMID: 29713125 Free PMC article. Review.
-
Regulation of macrophage activation in the liver after acute injury: Role of the fibrinolytic system.World J Gastroenterol. 2020 Apr 28;26(16):1879-1887. doi: 10.3748/wjg.v26.i16.1879. World J Gastroenterol. 2020. PMID: 32390699 Free PMC article. Review.
Cited by
-
Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis.Clin Gastroenterol Hepatol. 2017 Oct;15(10):1521-1530.e8. doi: 10.1016/j.cgh.2017.04.039. Epub 2017 May 4. Clin Gastroenterol Hepatol. 2017. PMID: 28479502 Free PMC article. Review.
-
Statin exposure is associated with reduced development of acute-on-chronic liver failure in a Veterans Affairs cohort.J Hepatol. 2022 May;76(5):1100-1108. doi: 10.1016/j.jhep.2021.12.034. Epub 2022 Jan 21. J Hepatol. 2022. PMID: 35066085 Free PMC article.
-
Characterization of a murine model of endothelial dysfunction induced by chronic intraperitoneal administration of angiotensin II.Sci Rep. 2021 Oct 27;11(1):21193. doi: 10.1038/s41598-021-00676-x. Sci Rep. 2021. PMID: 34707201 Free PMC article.
-
Loss of angiotensin converting enzyme II (ACE2) accelerates the development of liver injury induced by thioacetamide.Exp Anim. 2018 Feb 9;67(1):41-49. doi: 10.1538/expanim.17-0053. Epub 2017 Aug 25. Exp Anim. 2018. PMID: 28845018 Free PMC article.
-
CXCL10 Signaling Contributes to the Pathogenesis of Arthritogenic Alphaviruses.Viruses. 2020 Nov 2;12(11):1252. doi: 10.3390/v12111252. Viruses. 2020. PMID: 33147869 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous